Home > Opioid substitution therapy in resource-poor settings

Kermode, Michelle and Crofts, Nick and Kumar, Suresh and Dorabjee, Jimmy (2011) Opioid substitution therapy in resource-poor settings. Bulletin of the World Health Organization, 89, p. 243. doi: 10.2471/BLT.11.086850.

External website: http://www.who.int/bulletin/volumes/89/4/11-086850...

Approximately 10% of new HIV infections worldwide are attributable to injecting drug use, often of an opiate such as heroin.1 Opioid substitution therapy supplies illicit drug users with a replacement drug, a prescribed medicine such as methadone or buprenorphine, which is usually administered orally in a supervised clinical setting. The effectiveness of this therapy is recognized in developed countries, where the provision of opioid substitutes to opiate-dependent people is a fundamental component of the response to the dual public health problems of injecting drug use and HIV transmission.2 However, better prevention of HIV transmission among and from injecting drug users is still needed, especially in resource-poor settings.


Item Type
Article
Publication Type
International, Article
Drug Type
Opioid
Intervention Type
Harm reduction
Date
2011
Identification #
doi: 10.2471/BLT.11.086850
Page Range
p. 243
Publisher
World Health Organization
Volume
89
EndNote

Repository Staff Only: item control page